2023
DOI: 10.1101/2023.01.06.22283653
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

The incidence of COVID-19-related hospitalisation in migrants in the UK: Findings from the Virus Watch prospective community cohort study

Abstract: Background: Migrants in the UK may be at higher risk of SARS-CoV-2 exposure; however, little is known about their risk of COVID-19-related hospitalisation during waves 1-3 of the pandemic. Methods: We analysed secondary care data linked to Virus Watch study data for adults and estimated COVID-19-related hospitalisation incidence rates by migration status. To estimate the total effect of migration status on COVID-19 hospitalisation rates, we ran fixed-effect Poisson regression for wave 1 (01/03/2020-31/08/2020;… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
1
1

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 23 publications
0
2
0
Order By: Relevance
“…This will facilitate monitoring and response capabilities not only for COVID-19 but also other acute respiratory infectious diseases in the future. multiple clinical risk factors and studying of symptom profiles associated with different SARS-CoV-2 variants of concern [17][18][19][20][21][22][23][24][25][26].…”
Section: Discussionmentioning
confidence: 99%
“…This will facilitate monitoring and response capabilities not only for COVID-19 but also other acute respiratory infectious diseases in the future. multiple clinical risk factors and studying of symptom profiles associated with different SARS-CoV-2 variants of concern [17][18][19][20][21][22][23][24][25][26].…”
Section: Discussionmentioning
confidence: 99%
“…It also improved the reliability of the results by reducing the risk of underestimating COVID-19 incidence associated with the selfreporting of PCR/LFT test results (Figure 2A and 2B). In comparison to the ONS CIS and the national testing programme, our approach allowed the collection and analysis of multiple clinical risk factors and studying of symptom profiles associated with different SARS-CoV-2 variants of concern [17][18][19][20][21][22][23][24][25][26].…”
Section: Discussionmentioning
confidence: 99%